Cartesian Therapeutics, Inc. Contract Liability (Deferred Revenue)
Cartesian Therapeutics, Inc. (RNAC) had Contract Liability (Deferred Revenue) of $0 as of 2024-12-31, per its 10-K filed 2025-03-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:ContractWithCustomerLiabilityCurrent · last filed 2025-03-13
- 2024-12-31: Contract with Customer, Liability, Current $0.00.
- 2024-09-30: Contract with Customer, Liability, Current $0.00.
- 2024-06-30: Contract with Customer, Liability, Current $0.00.
- 2024-03-31: Contract with Customer, Liability, Current $412.00K.
| Period end | Contract with Customer, Liability, Current |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-13 |
| 2024-09-30 | $0.00 10-Q · filed 2024-11-07 |
| 2024-06-30 | $0.00 10-Q · filed 2024-08-08 |
| 2024-03-31 | $412.00K 10-Q · filed 2024-05-08 |
| 2023-12-31 | $2.31M 10-K · filed 2025-03-13 |
| 2023-09-30 | $4.14M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $4.23M 10-Q · filed 2023-08-17 |
| 2023-03-31 | $4.23M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $593.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | $3.82M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $15.97M 10-Q · filed 2022-08-08 |
| 2022-03-31 | $27.99M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $53.88M 10-K · filed 2023-03-02 |
| 2021-09-30 | $62.31M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $75.01M 10-Q · filed 2021-08-12 |
| 2021-03-31 | $75.76M 10-Q · filed 2021-05-13 |
| 2020-12-31 | $72.05M 10-K · filed 2022-03-10 |
| 2020-09-30 | $64.37M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $1.93M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.67M 10-Q · filed 2020-05-07 |
| 2019-12-31 | $1.67M 10-K · filed 2021-03-12 |
| 2019-09-30 | $1.02M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $1.02M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $959.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $959.00K 10-K · filed 2020-03-12 |
| 2018-09-30 | $1.86M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.92M 10-Q · filed 2018-08-08 |
| 2018-01-01 | $787.00K 10-K · filed 2019-03-15 |
| 2017-12-31 | $787.00K 10-K · filed 2019-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |